| |
 |
|
Dr. Anick Bérard's research team publications
Medications, pregnancy, and lactation
2011
| 1. |
Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. 2011 Oct 18;183(15):1713-20.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 2. |
Bérard A, Azoulay L, Nakhai-Pour HR, Moussally K. Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders. Dermatology. 2011;223(1):45-51.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 3. |
Bérard A. Antidepressants and spontaneous abortion.CMAJ. 2011 Aug; 183(11):1283.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 4. |
Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Bérard A. Antiepileptic drug use during pregnancy: Perinatal outcomes. Seizure. 2011 Nov;20(9):667-72.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 5. |
Santos F, Sheehy O, Perreault S, Ferreira E, Bérard A. Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study. BJOG. 2011 Oct;118(11):1374-82.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
2010 |
| 6. |
Ramos É, St-André M, Bérard A. Association between antidepressant use during pregnancy and infants born small for gestational age. Can J Psychiatry. 2010 Oct;55(10):643-52.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 7. |
Bérard A, Nakhai-Pour HR, Broy P. Antidepressant use (during pregnancy) and miscarriage. CMAJ. 2010 Jul 13;182(10):1079.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 8. |
Kulaga S, Bérard A. Congenital malformations: agreement between diagnostic codes in an administrative database and mothers' reports. J Obstet Gynaecol Can. 2010 Jun;32(6):549-54.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 9. |
Nakhai-Pour HR, Broy P, Bérard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ. 2010 Jul 13;182(10):1031-7.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 10. |
Nakhai-Pour HR, Rey E, Bérard A. Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol. 2010 Apr;89(2):147-54.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 11. |
Firoozi F, Lemière C, Ducharme FM, Beauchesne MF, Perreault S, Bérard A, Ferreira E, Forget A, Blais L. Effect of maternal moderate to severe asthma on perinatl outcomes.Respir Med. 2010 Sep;104(9):1278-87.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 12. |
Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
Med Care. 2010 May;48(5):418-25.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 13. |
Moussally K, Bérard A. Exposure to herbal products during pregnancy and the risk of preterm birth. Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):107-8.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 14. |
Chambers CD, Johnson DL, Robinson LK, Braddock SR, Xu R, Lopez-Jimenez J, Mirrasoul N, Salas E, Luo YJ, Jin S, Jones KL; Organization of Teratology Information Specialists Collaborative Research Group. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum. 2010 May;62(5):1494-503.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 15. |
Santos F, Oraichi D, Bérard A. Prevalence and predictors of anti-infective use during pregnancy. Pharmacoepidemiol Drug Saf. 2010 Apr;19(4):418-27.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 16. |
Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde L, Bérard A. Adherence level of antihypertensive agents in coronary artery disease.
Br J Clin Pharmacol. 2010 Jan;69(1):74-84.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 17. |
Gaedigk A, Jaime LK, Bertino JS Jr, Bérard A, Partt VM Bradfordand, LD, Leeder JS. Identification of Novel CYP2D7-2D6 Hybrids: Non-Functional and Functional Variants. Front Pharmacol. 2010;1:121.
www.ncbi.nlm.nih.gov/pubmed/21833166 |
| 18. |
Bérard A. Paraxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence? Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):171-4.
www.ncbi.nlm.nih.gov/pubmed/19950383 |
| 19. |
Broy P, Bérard A. Gestational exposure to antidepressants and the risk of spontaneous abortion: review. Curr Drug Deliv. 2010;7(1):76-92.
www.ncbi.nlm.nih.gov/pubmed/19863482 |
|
|
2009
| 20. |
Kulaga S, Zargarzadeh A, Bérard A. Prescriptions filled during pregnancy for drugs
with the potential of fetal harm. BJOG. 2009 Dec;116(13):1788-95. www.ncbi.nlm.nih.gov/pubmed/19832828 |
| 21. |
Broy P, Bérard A. Gestational exposure to antidepressants and the risk of spontaneous abortion: a review. Curr Drug Deliv. 2009 Oct 29. www.ncbi.nlm.nih.gov/pubmed/19863482
|
| 22. |
Dragomir A, Perreault S, Blais L, White M, Bérard A. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value Health. 2009 Aug 20.
www.ncbi.nlm.nih.gov/pubmed/19695008 |
| 23. |
Nakhai-Pour HR, Rey E, Bérard A. Discontinuation of antihypertensive drug use during the first trimester of pregnancy and the risk of preeclampsia and eclampsia among women with chronic hypertension. Am J Obstet Gynecol. 2009 Aug; 201(2):180.e1-8. www.ncbi.nlm.nih.gov/pubmed/19646568 |
| 24. |
Simoncelli M, Martin B, Bérard A. Antipressant use during pregnancy: A critical systematic review of the literature. Current Drug Saf. 2009 Sep 1. www.ncbi.nlm.nih.gov/pubmed/19534639 |
| 25. |
Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity. BMC Pregnancy Childbirth. 2009 Jul 2;9:26-34. www.ncbi.nlm.nih.gov/pubmed/19573237 |
| 26. |
Bérard A, Lacasse A. Validity of perinatal pharmacoepidemiologic studies using data from the RAMQ administrative database. Can J Clin Pharmacol. 2009;16(2):360-69. www.ncbi.nlm.nih.gov/pubmed/19553702 |
| 27. |
Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med. 2009 Aug;266(2):207-18. www.ncbi.nlm.nih.gov/pubmed/19623691 |
| 28. |
Perreault S, Elia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med. 2009 Jul;122(7):647-55. www.ncbi.nlm.nih.gov/pubmed/19559167 |
| 29. |
Perreault S, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L, White M, Pilon D. Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol. 2009 Oct;65(10):1013-24. www.ncbi.nlm.nih.gov/pubmed/19529927 |
| 30. |
Moussally K, Oraichi D, Bérard A. Herbal products use during pregnancy: prevalence and predictors. Pharmacoepidemiol Drug Safety. 2009 Jun;18(6):454-61. www.ncbi.nlm.nih.gov/pubmed/19326360 |
| 31. |
Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Determinants of early medical management of nausea and vomiting of pregnancy. Birth. 2009 Mar;36(1):70-7. www.ncbi.nlm.nih.gov/pubmed/19278386 |
| 32. |
Gendron MP, Martin B, Oraichi D, Bérard A. Health care providers' requests to Teratogen Information Services on medication use during pregnancy and lactation. Eur J Clin Pharmacol. 2009 May;65(5):523-31. www.ncbi.nlm.nih.gov/pubmed/19169677 |
| 33. |
Briggs GG, Plifka J, Balken L, Bérard A, Braddock S, Chambers C, Einarson A, Lyons Gaffaney C, Gaudette M, Koren G, Jones K, Lamm S, Miller R, Riordan S, Robinson L, Soldin O, Wisner K, Wolfe L. Better data needed from pregnancy registries. Birth Defect Res A Clin Mol Teratol. 2009 Feb;85(2):109-11. www.ncbi.nlm.nih.gov/pubmed/19107958 |
| 34. |
Lacasse A, Lagoutte A, Ferreira E, Bédard A. Metoclopramide and diphenhydramine in the treatment of hyperemesis gravidarum: effectiveness and predictors of rehospitalisation. Eur J Obstet Gynecol Reprod Biol. 2009 Mar;143(1):43-9. www.ncbi.nlm.nih.gov/pubmed/19135291 |
| 35. |
Kettani F, Dragomir A, Côté R, Roy L, Bérard A, Blais L, Lalonde L, Moreau P, Perreault S. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. 2009 Jan;40(1):213-20. www.ncbi.nlm.nih.gov/pubmed/19038916 |
2008
| 36. |
Ramos E, Ofori B, Oraichi D, Bérard A. Antidepressant therapy during pregnancy: an insight on its potential healthcare costs. Can J Clin Pharmacol. 2008 Fall;15(3):e398-410.www.ncbi.nlm.nih.gov/pubmed/18953084 |
| 37. |
Bérard A, Bréchat PH, Scapin MH. The priorities of public health must participate in the regulation of health networks. Presse Med. 2008 May;37(5 Pt 1):739-41. www.ncbi.nlm.nih.gov/pubmed/18329838 |
| 38. |
Nakhai-Pour HR, Bérard A. Major malformations after first trimester exposure to aspirin and NSAIDs. Expert Rev Clin Pharmacol. 2008;1:605-16.
http://www.expert-reviews.com/doi/abs/10.1586/17512433.1.5.605 |
| 39. |
Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M. Impact of adherence to statins on chronic heart failure in primary prevention. Br J Clin Pharmacol. 2008 Nov;66(5):706-16. www.ncbi.nlm.nih.gov/pubmed/18754842 |
| 40. |
Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Nausea and vomiting of pregnancy: what about quality of life? BJOG. 2008 Nov;115(12):1484-93. www.ncbi.nlm.nih.gov/pubmed/18752585 |
| 41. |
Bijur PE, Bérard A, Esses D, Calderon Y, Gallagher EJ. Race, ethnicity, and management of pain from long-bone fractures: a prospective study of two academic urban emergency departments. Acad Emerg Med. 2008 Jul;15(7):589-97. www.ncbi.nlm.nih.gov/pubmed/18691208 |
| 42. |
Ramos E, St-Andre M, Rey E, Bérard A. Risk of congenital malformations associated with the duration of exposure to antidepressants during the gestational period. Br.J.Psychiatry. 2008 May;192:344-50. www.ncbi.nlm.nih.gov/pubmed/18450657 |
| 43. |
Lacasse A, Bérard A. Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire. Health and Quality of life outcomes. 2008 May 9;6:32. www.ncbi.nlm.nih.gov/pubmed/18471301 |
| 44. |
Koren G, Dugoua JJ, Magee L, Vohra S, Matsui D, Bérard A et al. MotherNature: Establishing a Canadian Research Network for Natural Health Products (NHPs) during Pregnancy and Lactation. J.Complementary Alternative Med. 2008 May 8. [Epub ahead of print]. www.ncbi.nlm.nih.gov/pubmed/18466066 |
| 45. |
Bijur P, Bérard A, Nestor J, Calderon Y, Davitt M, Gallagher EJ. No racial or ethnic disparity in treatment of long-bone fractures. Am.J.Emerg.Med. 2008;26 (3):270-74. www.ncbi.nlm.nih.gov/pubmed/18358935 |
| 46. |
Ofori BD, Le TM, Bérard A. Risk factors associated with preterm birth according to gestational age at birth. Pharmacoepidemiol.Drug Saf 2008;Jun;17(6):556-64. www.ncbi.nlm.nih.gov/pubmed/18327870 |
| 47. |
Azoulay L, Blais L, Koren G, Lelorier J, Bérard A. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J.Clin.Psychiatry 2008;Apr;69(4):526-32. www.ncbi.nlm.nih.gov/pubmed/18363422 |
| 48. |
Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am.J.Obstet.Gynecol. 2008; Jan;198(1):71.e1-7. www.ncbi.nlm.nih.gov/pubmed/18166311 |
2007
| 49. |
Azoulay L, Oraichi D, Bérard A. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study. Br.J.Dermatol. 2007;Dec;157(6):1240-8. www.ncbi.nlm.nih.gov/pubmed/17970803 |
| 50. |
Fortin D, Préville M, Ducharme C, Hébert R, Trottier L, Grégoire JP, Allard J, Bérard A. Factors associated with long-term benzodiazepine use among elderly women and men in Quebec. J.Women Aging 2007;19:37-52. www.ncbi.nlm.nih.gov/pubmed/18032252 |
| 51. |
Bérard A, Ramos E. Antidepressants and pregnancy: risks and benefits for the mother and child. Med.Sci.(Paris) 2007;23(11):957-60. www.ncbi.nlm.nih.gov/pubmed/18021707 |
| 52. |
Ramos E, Oraichi D, Rey E, Blais L, Bérard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG. 2007;114(9):1055-64. www.ncbi.nlm.nih.gov/pubmed/17565615 |
| 53. |
Ofori B, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of statin drugs. Br.J.Clin.Pharmacol. 2007;64(4):496-509. www.ncbi.nlm.nih.gov/pubmed/17506782 |
| 54. |
Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br.J.Clin.Pharmacol. 2007;63(2):196-205. www.ncbi.nlm.nih.gov/pubmed/17214828 |
| 55. |
Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 2007;119(1):52-59. www.ncbi.nlm.nih.gov/pubmed/17200271 |
| 56. |
Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res.B Dev.Reprod.Toxicol. 2007;80(1):18-27. www.ncbi.nlm.nih.gov/pubmed/17187388 |
| 57. |
Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H et al. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Clin.Ther. 2007;29(5):918-26. www.ncbi.nlm.nih.gov/pubmed/17697910 |
| 58. |
Aubin PH, Cloutier K, Dubé F, Ferreira E, Bussières JF, Lebel D, Bérard A. Observance au traitement antirétroviral chez les femmes enceintes atteintes du VIH avant et après un conseil pharmaceutique. Pharmactuel 2007; 40 :15-24. ww.pharmactuel.com/sommaires%5C200701re.pdf |
| 59. |
Bouchard MH, Dragomir A, Blais L, Bérard A, Pilon D, Perreault S. Impact of adherence to statins on coronary artery disease in primary prevention. Br.J.Clin.Pharmacol. 2007;63(6):698-708. www.ncbi.nlm.nih.gov/pubmed/17214831 |
| 60. |
Atkinson S, Blanc A, Lebel D, Bussières JF, Bailey B, Bérard A. Risk of drug interactions among children accessing drugs through health Canada's special Access Programme. Can.J.Hosp.Pharm. 2007;60 (2):114-120. www.cshp.ca/productsServices/cjhp/2007/april_e.asp |
2006
| 61. |
Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study. Birth Defects Res.B Dev.Reprod.Toxicol. 2006;77(4):268-79. www.ncbi.nlm.nih.gov/pubmed/16929547 |
| 62. |
Azoulay L, Oraichi D, Bérard A. Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern? Eur.J.Clin.Pharmacol. 2006;62(8):667-74. www.ncbi.nlm.nih.gov/pubmed/16791584 |
| 63. |
Bijur PE, Bérard A, Esses D, Nestor J, Schechter C, Gallagher EJ. Lack of influence of patient self-report of pain intensity on administration of opioids for suspected long-bone fractures. J.Pain 2006;7(6):438-44.. www.ncbi.nlm.nih.gov/pubmed/16750800 |
2005
| 64. |
Azoulay L, Zargarzadeh A, Salahshouri Z, Oraichi D, Bérard A. Inappropriate medication prescribing in community-dwelling elderly people living in Iran. Eur.J.Clin.Pharmacol. 2005;61(12):913-19. www.ncbi.nlm.nih.gov/pubmed/16307268 |
| 65. |
Fortin D, Préville M, Ducharme C, Hébert R, Trottier L, Grégoire JP, Allard J, Bérard A. Factors associated with short- and long-term use of benzodiazepines in the elderly from Quebec. Can.J.Aging 2005;24:103-13. www.ncbi.nlm.nih.gov/pubmed/16082614 |
| 66. |
Laforest L, Pacheco Y, Bartsch P, Vincken W, Pietri G, Ernst P et al. Correlates of quality of life in patients with asthma. Ann.Allergy Asthma Immunol. 2005;94 (4):473-79. www.ncbi.nlm.nih.gov/pubmed/15875529 |
| 67. |
Bussières JF, Atkinson S, Blanc A, Lebel D, Bailey B, Bérard A. Utilisation du programme d'accès spécial de Santé Canada par les pharmaciens du Québec et comparaison avec d'autres pays. Can.J.Hosp.Pharm. 2005;58(2):79-89. www.cshp.ca/productsServices/cjhp/2005/april_e.asp |
| 68. |
Hohl CM, Robitaille C, Lord V, Dankoff J, Colacone A, Pham L et al. Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad.Emerg.Med. 2005;12 (3):197-205. www.ncbi.nlm.nih.gov/pubmed/15741581 |
2004
| 69. |
Souverein PC, Bérard A, Van Staa TP, Cooper C, Egberts AC, Leufkens HG et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004;90(8):859-65. www.ncbi.nlm.nih.gov/pubmed/15253953 |
| 70. |
Kahn SR, M'Lan CE, Lamping DL, Kurz X, Bérard A, Abenhaim L. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J.Thromb.Haemost. 2004;2(12):2146-51. www.ncbi.nlm.nih.gov/pubmed/15613019 |
| 71. |
Kahn SR, M'Lan CE, Lamping DL, Kurz X, Bérard A, Abenhaim LA. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: results from an international cohort study. J.Vasc.Surg. 2004;39:823-28. www.ncbi.nlm.nih.gov/pubmed/15071450 |
2003
| 72. |
Préville M, Ducharme C, Fortin D, Hébert R, Grégoire JP, Bérard A et al. Anxiolytic, sedative and hypnotic medication use in the elderly living in the community: Developing a conceptual framework. Sante Ment.Que. issue 2 2003;28(2):165-82. www.ncbi.nlm.nih.gov/pubmed/15470551 |
2002
| 73. |
Bérard A, Kurz X, Zuccarelli F, Abenhaim L. Validity of the Leg-O-Meter, an instrument to measure leg circumference. Angiology 2002;53(1):21-28. www.ncbi.nlm.nih.gov/pubmed/11863306 |
| 74. |
Bérard A, Abenhaim L, Platt R, Kahn SR, Steinmetz O. Risk factors for the first-time development of venous ulcers of the lower limbs: the influence of heredity and physical activity. Angiology 2002;53(6):647-57. www.ncbi.nlm.nih.gov/pubmed/12463617 |
|
|
 |
|